nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A43—Dexamethasone—psoriatic arthritis	0.303	0.412	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—psoriatic arthritis	0.0916	0.124	CbGbCtD
Zalcitabine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0442	0.0601	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0442	0.0601	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—psoriatic arthritis	0.0389	0.0529	CbGbCtD
Zalcitabine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0342	0.0465	CbGbCtD
Zalcitabine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0332	0.0451	CbGbCtD
Zalcitabine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0259	0.0352	CbGbCtD
Zalcitabine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0222	0.0302	CbGbCtD
Zalcitabine—CYP3A4—Betamethasone—psoriatic arthritis	0.0222	0.0302	CbGbCtD
Zalcitabine—CYP3A4—Prednisolone—psoriatic arthritis	0.0219	0.0298	CbGbCtD
Zalcitabine—CYP3A4—Prednisone—psoriatic arthritis	0.0207	0.0282	CbGbCtD
Zalcitabine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0203	0.0276	CbGbCtD
Zalcitabine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0129	0.0176	CbGbCtD
Zalcitabine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00056	0.0885	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.000551	0.0871	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.000551	0.0871	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.000543	0.0859	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.000538	0.0851	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.000535	0.0845	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.000535	0.0845	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.000522	0.0826	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.000511	0.0807	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.000499	0.0788	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.000496	0.0784	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.000484	0.0765	CbGdCrCtD
Zalcitabine—Alopecia—Betamethasone—psoriatic arthritis	0.000271	0.00105	CcSEcCtD
Zalcitabine—Discomfort—Prednisolone—psoriatic arthritis	0.000269	0.00104	CcSEcCtD
Zalcitabine—Hallucination—Prednisone—psoriatic arthritis	0.000266	0.00103	CcSEcCtD
Zalcitabine—Malaise—Triamcinolone—psoriatic arthritis	0.000265	0.00103	CcSEcCtD
Zalcitabine—Malaise—Methylprednisolone—psoriatic arthritis	0.000265	0.00103	CcSEcCtD
Zalcitabine—Vertigo—Triamcinolone—psoriatic arthritis	0.000264	0.00103	CcSEcCtD
Zalcitabine—Syncope—Triamcinolone—psoriatic arthritis	0.000264	0.00102	CcSEcCtD
Zalcitabine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000264	0.00102	CcSEcCtD
Zalcitabine—Syncope—Methylprednisolone—psoriatic arthritis	0.000263	0.00102	CcSEcCtD
Zalcitabine—Oedema—Prednisolone—psoriatic arthritis	0.000261	0.00101	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—psoriatic arthritis	0.000261	0.00101	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—psoriatic arthritis	0.000261	0.00101	CcSEcCtD
Zalcitabine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000258	0.001	CcSEcCtD
Zalcitabine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000258	0.001	CcSEcCtD
Zalcitabine—Shock—Prednisolone—psoriatic arthritis	0.000257	0.000997	CcSEcCtD
Zalcitabine—Cough—Triamcinolone—psoriatic arthritis	0.000257	0.000996	CcSEcCtD
Zalcitabine—Convulsion—Triamcinolone—psoriatic arthritis	0.000255	0.000989	CcSEcCtD
Zalcitabine—Tachycardia—Prednisolone—psoriatic arthritis	0.000255	0.000989	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000254	0.000987	CcSEcCtD
Zalcitabine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000254	0.000987	CcSEcCtD
Zalcitabine—Hypertension—Triamcinolone—psoriatic arthritis	0.000254	0.000985	CcSEcCtD
Zalcitabine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000253	0.000983	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000252	0.000979	CcSEcCtD
Zalcitabine—Myalgia—Triamcinolone—psoriatic arthritis	0.00025	0.000972	CcSEcCtD
Zalcitabine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00025	0.00097	CcSEcCtD
Zalcitabine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00025	0.00097	CcSEcCtD
Zalcitabine—Eye disorder—Prednisone—psoriatic arthritis	0.000249	0.000968	CcSEcCtD
Zalcitabine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000249	0.000966	CcSEcCtD
Zalcitabine—Depression—Methotrexate—psoriatic arthritis	0.000248	0.000962	CcSEcCtD
Zalcitabine—Flushing—Prednisone—psoriatic arthritis	0.000248	0.000962	CcSEcCtD
Zalcitabine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000248	0.000961	CcSEcCtD
Zalcitabine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000248	0.000961	CcSEcCtD
Zalcitabine—Discomfort—Triamcinolone—psoriatic arthritis	0.000247	0.00096	CcSEcCtD
Zalcitabine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000247	0.000958	CcSEcCtD
Zalcitabine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000245	0.00095	CcSEcCtD
Zalcitabine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000241	0.000937	CcSEcCtD
Zalcitabine—Malaise—Betamethasone—psoriatic arthritis	0.000241	0.000934	CcSEcCtD
Zalcitabine—Malaise—Dexamethasone—psoriatic arthritis	0.000241	0.000934	CcSEcCtD
Zalcitabine—Oedema—Triamcinolone—psoriatic arthritis	0.00024	0.000932	CcSEcCtD
Zalcitabine—Vertigo—Dexamethasone—psoriatic arthritis	0.00024	0.00093	CcSEcCtD
Zalcitabine—Vertigo—Betamethasone—psoriatic arthritis	0.00024	0.00093	CcSEcCtD
Zalcitabine—Syncope—Dexamethasone—psoriatic arthritis	0.000239	0.000929	CcSEcCtD
Zalcitabine—Syncope—Betamethasone—psoriatic arthritis	0.000239	0.000929	CcSEcCtD
Zalcitabine—Arrhythmia—Prednisone—psoriatic arthritis	0.000238	0.000926	CcSEcCtD
Zalcitabine—Infection—Triamcinolone—psoriatic arthritis	0.000238	0.000925	CcSEcCtD
Zalcitabine—Infection—Methylprednisolone—psoriatic arthritis	0.000238	0.000923	CcSEcCtD
Zalcitabine—Shock—Triamcinolone—psoriatic arthritis	0.000236	0.000916	CcSEcCtD
Zalcitabine—Insomnia—Prednisolone—psoriatic arthritis	0.000236	0.000916	CcSEcCtD
Zalcitabine—Alopecia—Prednisone—psoriatic arthritis	0.000236	0.000916	CcSEcCtD
Zalcitabine—Shock—Methylprednisolone—psoriatic arthritis	0.000236	0.000914	CcSEcCtD
Zalcitabine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000235	0.00091	CcSEcCtD
Zalcitabine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000235	0.00091	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—psoriatic arthritis	0.000234	0.00091	CcSEcCtD
Zalcitabine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000234	0.000909	CcSEcCtD
Zalcitabine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000234	0.000907	CcSEcCtD
Zalcitabine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000233	0.000903	CcSEcCtD
Zalcitabine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000232	0.000901	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000232	0.000899	CcSEcCtD
Zalcitabine—Convulsion—Dexamethasone—psoriatic arthritis	0.000231	0.000897	CcSEcCtD
Zalcitabine—Convulsion—Betamethasone—psoriatic arthritis	0.000231	0.000897	CcSEcCtD
Zalcitabine—Hypertension—Betamethasone—psoriatic arthritis	0.00023	0.000894	CcSEcCtD
Zalcitabine—Hypertension—Dexamethasone—psoriatic arthritis	0.00023	0.000894	CcSEcCtD
Zalcitabine—Myalgia—Betamethasone—psoriatic arthritis	0.000227	0.000882	CcSEcCtD
Zalcitabine—Myalgia—Dexamethasone—psoriatic arthritis	0.000227	0.000882	CcSEcCtD
Zalcitabine—Anxiety—Betamethasone—psoriatic arthritis	0.000226	0.000879	CcSEcCtD
Zalcitabine—Anxiety—Dexamethasone—psoriatic arthritis	0.000226	0.000879	CcSEcCtD
Zalcitabine—Discomfort—Dexamethasone—psoriatic arthritis	0.000224	0.000871	CcSEcCtD
Zalcitabine—Discomfort—Betamethasone—psoriatic arthritis	0.000224	0.000871	CcSEcCtD
Zalcitabine—Pain—Prednisolone—psoriatic arthritis	0.000223	0.000866	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—psoriatic arthritis	0.000223	0.000866	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000221	0.000859	CcSEcCtD
Zalcitabine—Vision blurred—Prednisone—psoriatic arthritis	0.000219	0.00085	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000219	0.000849	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000218	0.000847	CcSEcCtD
Zalcitabine—Oedema—Dexamethasone—psoriatic arthritis	0.000218	0.000845	CcSEcCtD
Zalcitabine—Oedema—Betamethasone—psoriatic arthritis	0.000218	0.000845	CcSEcCtD
Zalcitabine—Insomnia—Triamcinolone—psoriatic arthritis	0.000217	0.000843	CcSEcCtD
Zalcitabine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000217	0.000841	CcSEcCtD
Zalcitabine—Infection—Betamethasone—psoriatic arthritis	0.000216	0.00084	CcSEcCtD
Zalcitabine—Infection—Dexamethasone—psoriatic arthritis	0.000216	0.00084	CcSEcCtD
Zalcitabine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000216	0.000837	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000215	0.000835	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—psoriatic arthritis	0.000215	0.000834	CcSEcCtD
Zalcitabine—Anaemia—Prednisone—psoriatic arthritis	0.000215	0.000834	CcSEcCtD
Zalcitabine—Shock—Betamethasone—psoriatic arthritis	0.000214	0.000832	CcSEcCtD
Zalcitabine—Shock—Dexamethasone—psoriatic arthritis	0.000214	0.000832	CcSEcCtD
Zalcitabine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000214	0.00083	CcSEcCtD
Zalcitabine—Agitation—Prednisone—psoriatic arthritis	0.000214	0.000829	CcSEcCtD
Zalcitabine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000213	0.000828	CcSEcCtD
Zalcitabine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000213	0.000828	CcSEcCtD
Zalcitabine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000213	0.000825	CcSEcCtD
Zalcitabine—Tachycardia—Betamethasone—psoriatic arthritis	0.000213	0.000825	CcSEcCtD
Zalcitabine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000211	0.00082	CcSEcCtD
Zalcitabine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000211	0.000818	CcSEcCtD
Zalcitabine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000211	0.000817	CcSEcCtD
Zalcitabine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000211	0.000817	CcSEcCtD
Zalcitabine—Malaise—Prednisone—psoriatic arthritis	0.00021	0.000813	CcSEcCtD
Zalcitabine—Vertigo—Prednisone—psoriatic arthritis	0.000209	0.00081	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—psoriatic arthritis	0.000208	0.000809	CcSEcCtD
Zalcitabine—Syncope—Prednisone—psoriatic arthritis	0.000208	0.000809	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—psoriatic arthritis	0.000208	0.000807	CcSEcCtD
Zalcitabine—Anorexia—Betamethasone—psoriatic arthritis	0.000208	0.000806	CcSEcCtD
Zalcitabine—Anorexia—Dexamethasone—psoriatic arthritis	0.000208	0.000806	CcSEcCtD
Zalcitabine—Urticaria—Prednisolone—psoriatic arthritis	0.000207	0.000805	CcSEcCtD
Zalcitabine—Fatigue—Triamcinolone—psoriatic arthritis	0.000207	0.000803	CcSEcCtD
Zalcitabine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000206	0.000801	CcSEcCtD
Zalcitabine—Pain—Triamcinolone—psoriatic arthritis	0.000205	0.000797	CcSEcCtD
Zalcitabine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000204	0.000793	CcSEcCtD
Zalcitabine—Convulsion—Prednisone—psoriatic arthritis	0.000201	0.000781	CcSEcCtD
Zalcitabine—Hypertension—Prednisone—psoriatic arthritis	0.000201	0.000779	CcSEcCtD
Zalcitabine—Chills—Methotrexate—psoriatic arthritis	0.0002	0.000777	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000198	0.00077	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000198	0.00077	CcSEcCtD
Zalcitabine—Myalgia—Prednisone—psoriatic arthritis	0.000198	0.000768	CcSEcCtD
Zalcitabine—Arthralgia—Prednisone—psoriatic arthritis	0.000198	0.000768	CcSEcCtD
Zalcitabine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000198	0.000768	CcSEcCtD
Zalcitabine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000197	0.000766	CcSEcCtD
Zalcitabine—Anxiety—Prednisone—psoriatic arthritis	0.000197	0.000765	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—psoriatic arthritis	0.000197	0.000765	CcSEcCtD
Zalcitabine—Insomnia—Betamethasone—psoriatic arthritis	0.000197	0.000764	CcSEcCtD
Zalcitabine—Insomnia—Dexamethasone—psoriatic arthritis	0.000197	0.000764	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000196	0.00076	CcSEcCtD
Zalcitabine—Discomfort—Prednisone—psoriatic arthritis	0.000195	0.000759	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000192	0.000746	CcSEcCtD
Zalcitabine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000192	0.000744	CcSEcCtD
Zalcitabine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000192	0.000744	CcSEcCtD
Zalcitabine—Urticaria—Triamcinolone—psoriatic arthritis	0.000191	0.00074	CcSEcCtD
Zalcitabine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00019	0.000738	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00019	0.000738	CcSEcCtD
Zalcitabine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00019	0.000736	CcSEcCtD
Zalcitabine—Oedema—Prednisone—psoriatic arthritis	0.00019	0.000736	CcSEcCtD
Zalcitabine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000189	0.000735	CcSEcCtD
Zalcitabine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000189	0.000735	CcSEcCtD
Zalcitabine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000189	0.000735	CcSEcCtD
Zalcitabine—Infection—Prednisone—psoriatic arthritis	0.000188	0.000731	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—psoriatic arthritis	0.000188	0.000729	CcSEcCtD
Zalcitabine—Fatigue—Dexamethasone—psoriatic arthritis	0.000188	0.000729	CcSEcCtD
Zalcitabine—Fatigue—Betamethasone—psoriatic arthritis	0.000188	0.000729	CcSEcCtD
Zalcitabine—Shock—Prednisone—psoriatic arthritis	0.000187	0.000724	CcSEcCtD
Zalcitabine—Pain—Dexamethasone—psoriatic arthritis	0.000186	0.000723	CcSEcCtD
Zalcitabine—Pain—Betamethasone—psoriatic arthritis	0.000186	0.000723	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—psoriatic arthritis	0.000185	0.000718	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—psoriatic arthritis	0.000184	0.000715	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000183	0.000712	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—psoriatic arthritis	0.000183	0.00071	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—psoriatic arthritis	0.000181	0.000702	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00018	0.000699	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—psoriatic arthritis	0.00018	0.000697	CcSEcCtD
Zalcitabine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000179	0.000697	CcSEcCtD
Zalcitabine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000179	0.000697	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000178	0.000691	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000178	0.000691	CcSEcCtD
Zalcitabine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000177	0.000686	CcSEcCtD
Zalcitabine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000176	0.000685	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—psoriatic arthritis	0.000175	0.00068	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—psoriatic arthritis	0.000174	0.000677	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—psoriatic arthritis	0.000174	0.000675	CcSEcCtD
Zalcitabine—Urticaria—Betamethasone—psoriatic arthritis	0.000173	0.000671	CcSEcCtD
Zalcitabine—Urticaria—Dexamethasone—psoriatic arthritis	0.000173	0.000671	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000173	0.000671	CcSEcCtD
Zalcitabine—Dizziness—Prednisolone—psoriatic arthritis	0.000173	0.00067	CcSEcCtD
Zalcitabine—Asthenia—Triamcinolone—psoriatic arthritis	0.000172	0.000668	CcSEcCtD
Zalcitabine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000172	0.000668	CcSEcCtD
Zalcitabine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000172	0.000668	CcSEcCtD
Zalcitabine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000172	0.000668	CcSEcCtD
Zalcitabine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000172	0.000668	CcSEcCtD
Zalcitabine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000172	0.000667	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—psoriatic arthritis	0.000172	0.000666	CcSEcCtD
Zalcitabine—Pruritus—Triamcinolone—psoriatic arthritis	0.00017	0.000659	CcSEcCtD
Zalcitabine—Cough—Methotrexate—psoriatic arthritis	0.000169	0.000658	CcSEcCtD
Zalcitabine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000169	0.000658	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—psoriatic arthritis	0.000168	0.000653	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—psoriatic arthritis	0.000167	0.000648	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—psoriatic arthritis	0.000165	0.000642	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—psoriatic arthritis	0.000165	0.000642	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—psoriatic arthritis	0.000165	0.00064	CcSEcCtD
Zalcitabine—Rash—Prednisolone—psoriatic arthritis	0.000165	0.000639	CcSEcCtD
Zalcitabine—Dermatitis—Prednisolone—psoriatic arthritis	0.000164	0.000638	CcSEcCtD
Zalcitabine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000164	0.000636	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—psoriatic arthritis	0.000164	0.000635	CcSEcCtD
Zalcitabine—Headache—Prednisolone—psoriatic arthritis	0.000164	0.000635	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—psoriatic arthritis	0.000163	0.000634	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—psoriatic arthritis	0.00016	0.00062	CcSEcCtD
Zalcitabine—Dizziness—Triamcinolone—psoriatic arthritis	0.000159	0.000616	CcSEcCtD
Zalcitabine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000158	0.000615	CcSEcCtD
Zalcitabine—Infection—Methotrexate—psoriatic arthritis	0.000157	0.000611	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000156	0.000607	CcSEcCtD
Zalcitabine—Asthenia—Dexamethasone—psoriatic arthritis	0.000156	0.000606	CcSEcCtD
Zalcitabine—Asthenia—Betamethasone—psoriatic arthritis	0.000156	0.000606	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000155	0.000602	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000155	0.000602	CcSEcCtD
Zalcitabine—Pruritus—Betamethasone—psoriatic arthritis	0.000154	0.000598	CcSEcCtD
Zalcitabine—Pruritus—Dexamethasone—psoriatic arthritis	0.000154	0.000598	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—psoriatic arthritis	0.000154	0.000598	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000153	0.000595	CcSEcCtD
Zalcitabine—Vomiting—Triamcinolone—psoriatic arthritis	0.000153	0.000592	CcSEcCtD
Zalcitabine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000152	0.000591	CcSEcCtD
Zalcitabine—Rash—Triamcinolone—psoriatic arthritis	0.000151	0.000587	CcSEcCtD
Zalcitabine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000151	0.000587	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—psoriatic arthritis	0.000151	0.000586	CcSEcCtD
Zalcitabine—Rash—Methylprednisolone—psoriatic arthritis	0.000151	0.000586	CcSEcCtD
Zalcitabine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000151	0.000585	CcSEcCtD
Zalcitabine—Urticaria—Prednisone—psoriatic arthritis	0.000151	0.000585	CcSEcCtD
Zalcitabine—Headache—Triamcinolone—psoriatic arthritis	0.00015	0.000584	CcSEcCtD
Zalcitabine—Headache—Methylprednisolone—psoriatic arthritis	0.00015	0.000582	CcSEcCtD
Zalcitabine—Abdominal pain—Prednisone—psoriatic arthritis	0.00015	0.000582	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—psoriatic arthritis	0.00015	0.000582	CcSEcCtD
Zalcitabine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000149	0.000578	CcSEcCtD
Zalcitabine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000149	0.000578	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000144	0.00056	CcSEcCtD
Zalcitabine—Dizziness—Dexamethasone—psoriatic arthritis	0.000144	0.000559	CcSEcCtD
Zalcitabine—Dizziness—Betamethasone—psoriatic arthritis	0.000144	0.000559	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—psoriatic arthritis	0.000143	0.000556	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000141	0.000548	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—psoriatic arthritis	0.000141	0.000547	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00014	0.000542	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00014	0.000541	CcSEcCtD
Zalcitabine—Vomiting—Betamethasone—psoriatic arthritis	0.000138	0.000537	CcSEcCtD
Zalcitabine—Vomiting—Dexamethasone—psoriatic arthritis	0.000138	0.000537	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000138	0.000535	CcSEcCtD
Zalcitabine—Rash—Dexamethasone—psoriatic arthritis	0.000137	0.000533	CcSEcCtD
Zalcitabine—Rash—Betamethasone—psoriatic arthritis	0.000137	0.000533	CcSEcCtD
Zalcitabine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000137	0.000532	CcSEcCtD
Zalcitabine—Dermatitis—Betamethasone—psoriatic arthritis	0.000137	0.000532	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—psoriatic arthritis	0.000137	0.00053	CcSEcCtD
Zalcitabine—Headache—Betamethasone—psoriatic arthritis	0.000136	0.000529	CcSEcCtD
Zalcitabine—Headache—Dexamethasone—psoriatic arthritis	0.000136	0.000529	CcSEcCtD
Zalcitabine—Asthenia—Prednisone—psoriatic arthritis	0.000136	0.000528	CcSEcCtD
Zalcitabine—Pain—Methotrexate—psoriatic arthritis	0.000136	0.000526	CcSEcCtD
Zalcitabine—Pruritus—Prednisone—psoriatic arthritis	0.000134	0.000521	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000131	0.000507	CcSEcCtD
Zalcitabine—Diarrhoea—Prednisone—psoriatic arthritis	0.00013	0.000504	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00013	0.000503	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—psoriatic arthritis	0.000126	0.000489	CcSEcCtD
Zalcitabine—Dizziness—Prednisone—psoriatic arthritis	0.000125	0.000487	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000125	0.000486	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000125	0.000486	CcSEcCtD
Zalcitabine—Vomiting—Prednisone—psoriatic arthritis	0.000121	0.000468	CcSEcCtD
Zalcitabine—Rash—Prednisone—psoriatic arthritis	0.00012	0.000464	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—psoriatic arthritis	0.000119	0.000464	CcSEcCtD
Zalcitabine—Headache—Prednisone—psoriatic arthritis	0.000119	0.000461	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000117	0.000453	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—psoriatic arthritis	0.000114	0.000441	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—psoriatic arthritis	0.000112	0.000435	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000108	0.000421	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—psoriatic arthritis	0.000105	0.000407	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—psoriatic arthritis	0.000101	0.000391	CcSEcCtD
Zalcitabine—Rash—Methotrexate—psoriatic arthritis	9.99e-05	0.000388	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—psoriatic arthritis	9.98e-05	0.000388	CcSEcCtD
Zalcitabine—Headache—Methotrexate—psoriatic arthritis	9.93e-05	0.000385	CcSEcCtD
